Role of diastole in left ventricular function, I: Biochemical and biomechanical events

American Journal of Critical Care

Volumn 13, Issue 5, 2004, Pages 394-405

  Villars, Penelope S ^a   Hamlin, Shannan K ^a,b   Shaw, Andrew D ^b   Kanusky, Joseph T ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM;

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CELL LEVEL; CALCIUM CHANNEL L TYPE; CALCIUM CONDUCTANCE; DIASTOLE; ENERGY EXPENDITURE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE POTENTIAL; HEART MUSCLE RELAXATION; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; ION CHANNEL; REVIEW; SODIUM CHANNEL; SYSTOLE; VOLTAGE GATED CALCIUM CHANNEL;

EID: 7644231212     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2004.13.5.394     Document Type: Review

References (47)

1. Harvey W. On the Motion of the Heart and Blood in Animals, 1628. London, England: Bell; 1889.
2. Katz AM. Influence of altered inotropy and lusitropy on ventricular pressure-volume loops. J Am Coll Cardiol. 1988;11:438-445.
3. Fouad F, Stominski M, Tarazi R. Left ventricular diastolic function in hypertension: relation of left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3:1500-1506.
4. Vasan R, Levy D. Defining diastolic heart failure: a call for standardized criteria. Circulation. 2000;101:2118-2121.
5. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure, I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387-1393.
6. Opie LH. The Heart: Physiology, From Cell to Circulation. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998.
7. Hume JR, Duan D, Collier ML, Yamazaki J, Horowitz B. Anion transport in heart. Physiol Rev. 2000;80:31-81.
8. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res. 2000;87:275-281.
9. Solaro R, Rarick H. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res. 1998;83:471-480.
10. Solaro R. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res. 1999;84:122-124.
11. Huang X, Pi Y, Lee K, et al. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res. 1999;84:1-8.
12. McDonough J, Arrell D, Van Eyk J. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. 1999;84:9-20.
13. 2+ release mechanism, Ca2+ sparks, and local control of excitation-contraction coupling in normal heart muscle. Circ Res. 1999;85:770-776.
14. Bers DM, Fill M. Coordinated feet and the dance of ryanodine receptors. Science. 1998;281:790-791.
15. Ferrier GR, Howlett SE. Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction. Am J Physiol Heart Circ Physiol. 2001;280:H1928-H1944.
16. Mason C, Ferrier G. Tetracaine can inhibit contraction initiated by a voltage-sensitive release mechanism in guinea-pig ventricular myocytes. J Physiol. 1999;519(pt 3):851-865.
17. Hasenfuss G. Alteration of calcium regulatory proteins in heart failure. Cardiovasc Res. 1998;37:279-289.
18. Marks A. Cardiac intracellular calcium release channels: role in heart failure. Circ Res. 2000;87:8-11.
19. Marks A. Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol. 1997;272:H597-H605.
20. Zile M, Brutsaert D. New concepts in diastolic dysfunction and diastolic heart failure, II: causal mechanisms and treatment. Circulation. 2002;105:1503-1508.
21. Koss K, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res. 1996;79:1059-1063.
22. Frank K, Kranias EG. Phospholamban and cardiac contractility. Ann Med. 2000;32:572-578.
23. Koss KL, Grupp I, Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res Cardiol. 1997;92(suppl 1):17-24.
24. Simmerman HKBJ, Larry R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev. 2001;78:921-947.
25. Wilson EM, Spinale FG. Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. Ann Med. 2001;33:623-634.
26. Libby P, Lee R. Matrix matters. Circulation. 2000;102:1874-1876.
27. Ross R, Borg T. Integrins and the myocardium. Circ Res. 2001;88:1112-1119.
28. Giancotti F, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
29. Avendano G, Agarwal R, Bashey R, et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes. 1999;48:1443-1447.
30. Vlassara H, Bucala R. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes. 1996;45(suppl 3):S65-S66.
31. Spinale F, Coker M, Krombach S, et al. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res. 1999;85:364-376.
32. Kim H, Dalal S, Young E, Legato M, Weisfeldt M, D'Armienta J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest. 2000;106:857-866.
33. Cheung B, Kumana C. Natriuretic peptides: relevance in cardiovascular disease. JAMA. 1998;280:1983-1984.
34. Suzuki T, Yamazaki T, Yazaki Y. The role of natriuretic peptides in the cardiovascular system. Cardiovasc Res. 2001;51:489-494.
35. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings [published correction appears in Circulation. 2002;106:387]. Circulation. 2002;105:595-601.
36. Yamamoto K, Burnett JC Jr, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-994.
37. Maisel A, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
38. Courtois M, Ludbrook PA, Kovacs SJ. Unsolved problems in diastole. Cardiol Clin. 2000;18:653-667.
39. Hunter WC. Role of myofilaments and calcium handling in left ventricular relaxation. Cardiol Clin. 2000;18:453-457.
40. Solomon S, Nikolic S, Frater R, Yellin E. Contraction-relaxation coupling: determination of the onset of diastole. Am J Physiol. 1999;277(1 pt 2):H23-H27.
41. Weisfeldt M, Frederiksen J, Yin F, Weiss J. Evidence of incomplete left ventricular relaxation in the dog. J Clin Invest. 1978;62:1296-1302.
42. Smiseth OA, Thompson CR. Atrioventricular filling dynamics, diastolic function and dysfunction. Heart Fail Rev. 2000;5:291-299.
43. Brutsaert DL, Sys SU. Diastolic dysfunction in heart failure. J Card Fail. 1997;3:225-242.
44. Little W, Downes T. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis. 1990;32:273-290.
45. Gaasch W. Passive elastic properties of the left ventricle. In: Lewinter M, ed. Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia. Pa: Lea & Febiger; 1994:143-149.
46. Rademakers F, Buchalter M, Rogers W, et al. Dissociation between left ventricular untwisting and filling: accentuation by catecholamines. Circulation. 1992;85:1572-1581.
47. Thys D, Dauchot P, Hillel Z. Advances in cardiovascular physiology. In: Kaplan J, ed. Cardiac Anesthesia. Philadelphia, Pa: WB Saunders Co; 1999:217-240.